TRPV4 and atrial fibrillation: We also show for the first time, the successful gene editing of human herniated and degenerated AF cells (Pfirrmann grade 2 to 4) via CRISPR-Cas9 for the purpose of knocking out the TRPV4 gene and investigating its role.